Market Overview

The global Oral Rotavirus Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Oral Rotavirus Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

Oral Rotavirus Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Oral Rotavirus Vaccine market has been segmented into

Rotarix

RotaTeq

Rotavac

Rotavin-M1

Lanzhou lamb

By Application, Oral Rotavirus Vaccine has been segmented into:

Hospital

Vaccination Station

Other

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Oral Rotavirus Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Oral Rotavirus Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Oral Rotavirus Vaccine market.

The report offers in-depth assessment of the growth and other aspects of the Oral Rotavirus Vaccine market in important countries (regions), including:

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, etc.)

Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Oral Rotavirus Vaccine Market Share Analysis

Oral Rotavirus Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Oral Rotavirus Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Oral Rotavirus Vaccine sales, revenue and market share for each player covered in this report.

The major players covered in Oral Rotavirus Vaccine are:

GSK

Biological E. Limited

Sanofi-Pasteur

Merck

Sinovac Biotech

China National Biotec Group

Among other players domestic and global, Oral Rotavirus Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Oral Rotavirus Vaccine product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Oral Rotavirus Vaccine, with price, sales, revenue and global market share of Oral Rotavirus Vaccine in 2018 and 2019.

Chapter 3, the Oral Rotavirus Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Oral Rotavirus Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.

Chapter 12, Oral Rotavirus Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.

Chapter 13, 14 and 15, to describe Oral Rotavirus Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview

1.1 Oral Rotavirus Vaccine Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Oral Rotavirus Vaccine Revenue by Type: 2015 VS 2019 VS 2025

1.2.2 Rotarix

1.2.3 RotaTeq

1.2.4 Rotavac

1.2.5 Rotavin-M1

1.2.6 Lanzhou lamb

1.3 Market Analysis by Application

1.3.1 Overview: Global Oral Rotavirus Vaccine Revenue by Application: 2015 VS 2019 VS 2025

1.3.2 Hospital

1.3.3 Vaccination Station

1.3.4 Other

1.4 Overview of Global Oral Rotavirus Vaccine Market

1.4.1 Global Oral Rotavirus Vaccine Market Status and Outlook (2015-2025)

1.4.2 North America (United States, Canada and Mexico)

1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)

1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.5 South America, Middle East & Africa

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 GSK

2.1.1 GSK Details

2.1.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 GSK SWOT Analysis

2.1.4 GSK Product and Services

2.1.5 GSK Oral Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.2 Biological E. Limited

2.2.1 Biological E. Limited Details

2.2.2 Biological E. Limited Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 Biological E. Limited SWOT Analysis

2.2.4 Biological E. Limited Product and Services

2.2.5 Biological E. Limited Oral Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.3 Sanofi-Pasteur

2.3.1 Sanofi-Pasteur Details

2.3.2 Sanofi-Pasteur Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 Sanofi-Pasteur SWOT Analysis

2.3.4 Sanofi-Pasteur Product and Services

2.3.5 Sanofi-Pasteur Oral Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.4 Merck

2.4.1 Merck Details

2.4.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 Merck SWOT Analysis

2.4.4 Merck Product and Services

2.4.5 Merck Oral Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.5 Sinovac Biotech

2.5.1 Sinovac Biotech Details

2.5.2 Sinovac Biotech Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 Sinovac Biotech SWOT Analysis

2.5.4 Sinovac Biotech Product and Services

2.5.5 Sinovac Biotech Oral Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.6 China National Biotec Group

2.6.1 China National Biotec Group Details

2.6.2 China National Biotec Group Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 China National Biotec Group SWOT Analysis

2.6.4 China National Biotec Group Product and Services

2.6.5 China National Biotec Group Oral Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

3 Sales, Revenue and Market Share by Manufacturer

3.1 Global Oral Rotavirus Vaccine Sales and Market Share by Manufacturer (2018-2019)

3.2 Global Oral Rotavirus Vaccine Revenue and Market Share by Manufacturer (2018-2019)

3.3 Market Concentration Rate

3.3.1 Top 3 Oral Rotavirus Vaccine Manufacturer Market Share in 2019

3.3.2 Top 6 Oral Rotavirus Vaccine Manufacturer Market Share in 2019

3.4 Market Competition Trend

4 Global Market Analysis by Regions

4.1 Global Oral Rotavirus Vaccine Sales, Revenue and Market Share by Regions

4.1.1 Global Oral Rotavirus Vaccine Sales and Market Share by Regions (2015-2020)

4.1.2 Global Oral Rotavirus Vaccine Revenue and Market Share by Regions (2015-2020)

4.2 North America Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)

4.3 Europe Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)

4.4 Asia-Pacific Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)

4.5 South America Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)

4.6 Middle East and Africa Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)

5 North America by Country

5.1 North America Oral Rotavirus Vaccine Sales, Revenue and Market Share by Country

5.1.1 North America Oral Rotavirus Vaccine Sales and Market Share by Country (2015-2020)

5.1.2 North America Oral Rotavirus Vaccine Revenue and Market Share by Country (2015-2020)

5.2 United States Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)

5.3 Canada Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)

5.4 Mexico Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)

6 Europe by Country

6.1 Europe Oral Rotavirus Vaccine Sales, Revenue and Market Share by Country

6.1.1 Europe Oral Rotavirus Vaccine Sales and Market Share by Country (2015-2020)

6.1.2 Europe Oral Rotavirus Vaccine Revenue and Market Share by Country (2015-2020)

6.2 Germany Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)

6.3 UK Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)

6.4 France Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)

6.5 Russia Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)

6.6 Italy Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)

7 Asia-Pacific by Regions

7.1 Asia-Pacific Oral Rotavirus Vaccine Sales, Revenue and Market Share by Regions

7.1.1 Asia-Pacific Oral Rotavirus Vaccine Sales and Market Share by Regions (2015-2020)

7.1.2 Asia-Pacific Oral Rotavirus Vaccine Revenue and Market Share by Regions (2015-2020)

7.2 China Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)

7.3 Japan Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)

7.4 Korea Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)

7.5 India Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)

7.6 Southeast Asia Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)

7.7 Australia Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)

8 South America by Country

8.1 South America Oral Rotavirus Vaccine Sales, Revenue and Market Share by Country

8.1.1 South America Oral Rotavirus Vaccine Sales and Market Share by Country (2015-2020)

8.1.2 South America Oral Rotavirus Vaccine Revenue and Market Share by Country (2015-2020)

8.2 Brazil Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)

8.3 Argentina Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)

9 Middle East & Africa by Countries

9.1 Middle East & Africa Oral Rotavirus Vaccine Sales, Revenue and Market Share by Country

9.1.1 Middle East & Africa Oral Rotavirus Vaccine Sales and Market Share by Country (2015-2020)

9.1.2 Middle East & Africa Oral Rotavirus Vaccine Revenue and Market Share by Country (2015-2020)

9.2 Saudi Arabia Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)

9.3 Turkey Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)

9.4 Egypt Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)

9.5 South Africa Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)

10 Market Segment by Type

10.1 Global Oral Rotavirus Vaccine Sales and Market Share by Type (2015-2020)

10.2 Global Oral Rotavirus Vaccine Revenue and Market Share by Type (2015-2020)

10.3 Global Oral Rotavirus Vaccine Price by Type (2015-2020)

11 Global Oral Rotavirus Vaccine Market Segment by Application

11.1 Global Oral Rotavirus Vaccine Sales Market Share by Application (2015-2020)

11.2 Global Oral Rotavirus Vaccine Revenue Market Share by Application (2015-2020)

11.3 Global Oral Rotavirus Vaccine Price by Application (2015-2020)

12 Market Forecast

12.1 Global Oral Rotavirus Vaccine Sales, Revenue and Growth Rate (2021-2025)

12.2 Oral Rotavirus Vaccine Market Forecast by Regions (2021-2025)

12.2.1 North America Oral Rotavirus Vaccine Market Forecast (2021-2025)

12.2.2 Europe Oral Rotavirus Vaccine Market Forecast (2021-2025)

12.2.3 Asia-Pacific Oral Rotavirus Vaccine Market Forecast (2021-2025)

12.2.4 South America Oral Rotavirus Vaccine Market Forecast (2021-2025)

12.2.5 Middle East & Africa Oral Rotavirus Vaccine Market Forecast (2021-2025)

12.3 Oral Rotavirus Vaccine Market Forecast by Type (2021-2025)

12.3.1 Global Oral Rotavirus Vaccine Sales Forecast by Type (2021-2025)

12.3.2 Global Oral Rotavirus Vaccine Market Share Forecast by Type (2021-2025)

12.4 Oral Rotavirus Vaccine Market Forecast by Application (2021-2025)

12.4.1 Global Oral Rotavirus Vaccine Sales Forecast by Application (2021-2025)

12.4.2 Global Oral Rotavirus Vaccine Market Share Forecast by Application (2021-2025)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

15.3 Disclaimer

15.4 About US

List of Tables

Table 1. Global Oral Rotavirus Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025

Table 2. Breakdown of Oral Rotavirus Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)